Icahn School of Medicine at Mount Sinai
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Icahn School of Medicine at Mount Sinai sits in the top decile of US sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count).
Icahn School of Medicine at Mount Sinai: 708 sponsored US clinical trials, 163 recruiting.
Icahn School of Medicine at Mount Sinai sponsors 708 registered US clinical trials on ClinicalTrials.gov, 163 of them currently recruiting, and 423 completed. 88 of these trials are in Phase 3-4 (later-stage) and 138 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 7 trials.
Top-decile sponsor footprint
Icahn School of Medicine at Mount Sinai ranks in the top decile of sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
423 of 499 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
708 total, page 6 of 15
Bio-Experiential Spaces for Mental Health in Healthworkers
NCT05227352
Cognitive Rehabilitation for Post-COVID-19 Cognitive Impairment
NCT05498493
Erector Spinae Block for Spine Surgery
NCT05417113
Electrophysiologic Studies of Cognition in Epilepsy Patients
NCT05769634
Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study
NCT05535660
Closed Incision Negative Pressure Wound Therapy vs. Foam as Post Operative Dressing
NCT05427916
Vagus Nerve Stimulation as Treatment for Long Covid
NCT05608629
JAK Inhibition in Food Allergy
NCT05069831
Translating Scientific Evidence Into Practice Using Digital Medicine and Electronic Patient Reported Outcomes
NCT04345393
Circumferential Vertebral Reconstruction of Osteoporotic Compression Fractures Using a Novel Bipedicular Peek Implant
NCT05337696
Microcurrent Device (TIVIC Health)
NCT05198518
An Intuitive, Non-intrusive, Approach to Reduce Patient Harm From Inappropriate Dosing of High-risk Drugs in Older Adult Patients Across an Urban Safety Net Hospital System
NCT05218343
Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors
NCT05279690
Integrated Intervention for Breast Cancer Survivors With Diabetes
NCT05092477
The Effect of Structured Lifestyle Modification and Yoga Practice on Metabolic Processes Associated With Cardiovascular Disease
NCT05250310
A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism
NCT05187377
The Effects of a Music Therapy Respiratory Protocol on Post-Covid-19 Respiratory Symptoms
NCT05231512
Rhythmic Light Therapy for Alzheimer's Disease Patients
NCT05015478
Thulium vs. Hol:YAG Laser
NCT05808257
Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia
NCT05519137
Does a Minimally Invasive Approach to Liver Resection Improve Postoperative Outcomes?
NCT07169877
Cognitive Reappraisal Training for Borderline Personality
NCT04967222
Lighting Intervention to Improve Sleep
NCT05757414
Pelvic Floor Disorder Education in Prenatal Care
NCT05127512
Trial Assessing Renal Damage During Ureteroscopy
NCT05350423
ED Initiated Oral Naltrexone for AUD
NCT04817410
Neurocognition After Perturbed Sleep
NCT05032963
The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
NCT05101798
Cardiovascular Analysis of PEM
NCT04740736
Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer
NCT05224869
Targeting IL-17A for Treatment-Resistant Depression
NCT04979910
e-Motivación: Developing and Pilot Testing an App to Improve Latinos' Screening Colonoscopy Rates
NCT04987788
Investigation of the Pharmacokinetic Profile of CBD - Phase 1 ANANDA
NCT05023070
Barbed Suture for Hysterotomy Closure During Cesarean Section
NCT04622267
Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic
NCT04654481
Comparison of Glycemic Control With Smartphone Application
NCT05592860
An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women
NCT05038878
Increasing Breast Cancer Screening in Chinese Immigrants
NCT05089292
Short Sessions of HRV Biofeedback
NCT05958329
The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment
NCT04073628
Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment
NCT05411822
The Personal Patient Profile Decision Support for Patients With Bladder Cancer
NCT05033067
Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD
NCT04889664
Dupilumab in the Treatment of Keloids
NCT04988022
Caregiver Support and Post-operative Convalescence
NCT04897061
Daily Versus Every Other Day Glucose Monitoring in Gestational Diabetes Mellitus
NCT04857073
Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic
NCT04431297
Noom Health for Weight Management
NCT04797169
Vestibular Caloric Stimulation and the Modulation of Pain in Fibromyalgia
NCT05004194
Remote Gamified Sensory Perceptual Training for Patients With Fibromyalgia: a Feasibility Trial
NCT04919525
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 57 |
| Phase 2 | 81 |
| Phase 3 | 21 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Icahn School of Medicine at Mount Sinai pipeline
163 recruiting of 708 indexed (23% open); 423 completed (60%).
Phase mix: 88 late (III/IV) vs 138 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Icahn School of Medicine at Mount Sinai: open-pipeline peers nationwide
Peers matched on 708 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Icahn School of Medicine at Mount Sinai sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 708 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
- University of Miami · 721 trials · 20% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this Icahn School of Medicine at Mount Sinai page
708 registered trials is a research-attention snapshot, not an endorsement of Icahn School of Medicine at Mount Sinai or any single study.
- 163 of Icahn School of Medicine at Mount Sinai's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Icahn School of Medicine at Mount Sinai studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Icahn School of Medicine at Mount Sinai pipeline card: 708 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.